VL:VH domain rotations in engineered antibodies: Crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs
Mark J. Banfield(John Innes Centre), R.L. Brady(Bristol Institute for Transfusion Sciences), David J. King(AnaBios (United States)), Angela Mountain(CTI BioPharma (United Kingdom))
Proteins Structure Function and Bioinformatics
October 1, 1997
Cited by 50
Related Papers
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
|Molecular Immunology|1993|243
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
|PubMed|1996|212
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3
|Protein Engineering Design and Selection|1994|122